Tri-estarylla Kit
Product Images NDC 50090-7861

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tri-estarylla (NDC 50090-7861). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907861)

Tri-Estarylla kit containing tablets of norgestimate and ethinyl estradiol by A-S Medication Solutions. The label shows dosage strength, instructions, and packaging details, including a count of 28 tablets per protected unit, manufactured by A-S Medication Solutions in Libertyville, Illinois.*

FDA Label Image

Tri-estarylla-blister (Tri Estarylla Blister)

The image is a dosage schedule card for Tri-Estarylla, showing a 28-day weekly calendar with circles for each day labeled Sunday through Saturday. It guides the user through Weeks 1 to 4, with arrows indicating the order of tablet intake. The card lists active ingredients as norgestimate and ethinyl estradiol tablets with specific dosages.*

FDA Label Image

Chemical Structure 1 (Tri Estarylla Chemical Struc)

Chemical structures of the active ingredients norgestimate and ethinyl estradiol as depicted in the image. Each structure shows the molecular formula with rings and functional groups detailed clearly.*

FDA Label Image

Fig 2 (Tri Estarylla Fig 1)

A forest plot chart displaying effect estimates (OR/RR) with confidence intervals from various women's health studies between 2002 and 2017. Each study is listed on the left, with horizontal lines and points indicating estimates around the value 1 on the x-axis labeled 'Effect Estimate (OR/RR)'. Confidence intervals are presented numerically on the right for each study.*

FDA Label Image

Chart (Tri Estarylla Fig 2)

An effectiveness chart illustrating birth control methods arranged by pregnancy rates per 100 women per year. It categorizes methods from fewer than 1 pregnancy to 85 or more pregnancies, listing implants, injections, intrauterine devices, and sterilization as most effective, followed by birth control pills, skin patches, and vaginal rings with hormones. Condoms and diaphragms are less effective, with behavioral methods like abstaining during fertile days, spermicide, and withdrawal less effective, and no birth control yielding the most pregnancies.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.